drugset / Trial / NCT01737931

A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject

NCT01737931

Phase 1 Completed 120 enrolled Otsuka Pharmaceutical Co., Ltd.
RandomizedParallel-groupOpen-labelTreatment

Summary

To investigate the efficacy of symptomatic therapy with topical steroids and antihistamines for application site reaction (ASR) after administration of SPM 962 in healthy subjects

Timeline

Start
2012-08
Primary completion
2012-10
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexamethasone Small molecule 1 unknown Topical
Subject Diphenhydramine Unknown 10 unknown Topical

Indications

No indication recorded.